IP Library › Assignment 059588/0608
Patent Assignment
Reel/Frame 059588/0608

Assignment of Assignor's Interest

Recorded: 2022-04-13 Pages: 16
Assignors
TOKYO WOMEN'S MEDICAL UNIVERSITY
Executed: 2022-04-08
HIROSHIMA UNIVERSITY
Executed: 2021-11-09
Assignees
TOKYO WOMEN'S MEDICAL UNIVERSITY
8-1, KAWADA-CHO, SHINJUKU-KU, TOKYO, 1628666, JAPAN
HIROSHIMA UNIVERSITY
3-2 KAGAMIYAMA 1-CHOME, HIGASHI-HIROSHIMA-SHI, HIROSHIMA, 7398511, JAPAN
CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, UKIMA 5-CHOME, KITA-KU, TOKYO, 1158543, JAPAN
Covered Property (1)
Therapeutic Agent for Urological Cancer Which Is Characterized by Being Administered with Il-6 Inhibitor and CCR2 Inhibitor in Combination
Application: 17/601,831 →
Publication: US 2022/0204608
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 13, 2022
From: KOBATAKE, KOHEI
To: HIROSHIMA UNIVERSITY
Reel/Frame 059587/0244 →
Assignment of Assignor's Interest Apr 13, 2022
From: HONDA, HIROAKI
To: TOKYO WOMEN'S MEDICAL UNIVERSITY
Reel/Frame 059587/0902 →